GO
Loading...

Glaxo Wins FDA Approval for Allergy Spray

GlaxoSmithKline won U.S. approval for its Veramyst nasal spray to relieve seasonal and perennial allergies, a U.S. Food and Drug Administration spokeswoman said on Friday.

The drug is approved for use in adults and children two years of age and older, according to Kimberly Rawlings of the FDA.

Analysts have projected peak sales of up to $1 billion a year for the allergy treatment, which is chemically known as fluticasone furoate.

Don't Miss

U.S. Video